Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-027911
Filing Date
2016-07-26
Accepted
2016-07-26 17:17:55
Documents
2
Period of Report
2016-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1795
2 POWER OF ATTORNEY ex24friedman.txt EX-24 4986
  Complete submission text file 0001179110-16-027911.txt   8131
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
FRIEDMAN PAUL A (Reporting) CIK: 0001236927 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 161785059